Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

1(33.3%)

Phase 2

1(33.3%)

Phase 4

1(33.3%)

3Total

Phase 1(1)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT06876545Not Yet Recruiting

"Vitamin C Deficiency in Hospitalized Adults: Systematic Screening Vs. Traditional Judgment - a Before-and-After Observational Study"

Role: collaborator

NCT03158727Phase 1Completed

Cx611-0204 SEPCELL Study

Role: collaborator

NCT00559195Phase 2Completed

Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors

Role: lead

NCT00559676Phase 4Completed

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

Role: lead

All 4 trials loaded